The Caprolactam Production in North America Is Anticipated to Drop to 550 Thousand Tons in 2023

SOFIA, Bulgaria - Aug. 21, 2019 - PRLog -- According to a recently published report about the North American caprolactam market, it was equal to 526 thousand tons in 2013. The largest country market within the region was the United States, which in 2013 accounted for a share of 94% of the total in volume terms. Until 2023, the North American market is forecast to reach 680 thousand tons, thus growing at a CAGR of about 0.6% per annum in the period 2018-2023. This is a slight slowdown, compared to the growth at a CAGR of around 5.7% per year, registered in 2013-2017.

The analytical research projects that the North American production of caprolactam is likely to drop to around 550 thousand tons in the medium term. Similar dynamics of the overall installed production capacities and their annual average utilization rates in the region are also expected. In addition, the market is forecast to remain relatively unbalanced in terms of supply and demand, showing mixed dynamics in the medium term.

When it comes to corporate restructurings, most of the large companies within the chemical industry have been following the principle "small is better than big" over the past few years. Renown companies such as Dow Chemicals, BASF, Bayer among others have been looking at divesting as a strategic tool, allowing them to focus on specific businesses. Particularly on the caprolactam market, Honeywell International Inc. completed the spin-off of its Resins and Chemicals business. As of 2016, the new publicly traded company AdvanSix Inc. has been focused on the manufacture of nylon 6 and caprolactam.

As an overall, the report presents a strategic analysis of the caprolactam market in North America and a forecast for its development in the medium term. It provides a comprehensive overview of the market, its dynamics, structure, characteristics, main players, production capacities, trends, prices, production, imports, exports, growth and demand drivers, and all other important factors, influencing its development. The report focuses on both product and country breakdown, offering a larger perspective on the regional market dynamics as well as information on each individual country within the region.

The research report has been prepared using the unique Williams and Marshall Strategy's methodology, including a blend of qualitative and quantitative data. The information comes from official sources and insights from market experts (representatives of the main market participants), gathered by semi-structured interviews.

The report includes information on the following companies:

•        Advansix;

•        Basf Corp.;

•        Fibrant.

You can find more information about this report here: https://www.wm-strategy.com/catalog/product/view/id/125402/s/north-america-caprolactam-market/.